“…This study carried out phenotypical and immunological characterization of a human neural stem cell line, named HB1.F3, which was previously reported to have stem cell properties [5,6,[27][28][29], and tested the feasibility of modifying the cells to have reduced levels of MHC class I antigens by the transfection of the hCMV genes, US2, 3, 6, and 11, into the NSCs in order to overcome the immune rejection in a future study of stem cell transplantation.…”